SIRT-1 activation also prevents the development of HFD-induced insulin resistance and to improve insulin sensitivity in T2D animal models through deacetylation of PGC-1α and by increasing mitochondrial function [111,112]. Here, PPARGC1A is linked to type 2 diabetes mellitus.